The ADC, generated by MedImmune and known as MEDI-547, effectively killed EphA2+ cells in vitro via caspase-mediated cell death, and more effectively inhibited tumor growth in mouse xenograft models, compared to naked 1C1 [34,35,36]. This evidence concerns the gene EPHA2 and neoplasm.